Article: Other News To Note.

Access Pharmaceuticals Inc., of Dallas, saw its stock fall about 35.8 percent Thursday following the release of its second-quarter earnings late Wednesday. Access's statement reported a net loss of $3.8 million, or 24 cents per share, for the three months ending June 30, compared to a loss of $2.6 million, or 17 cents per share for the same quarter in 2004. The company had cash, cash equivalents and short-term investments totaling about $1.3 million. Shares of Access (AMEX:AKC) closed at 88 cents Thursday, down 49 cents.

Acumen Pharmaceutical Inc., of South San Francisco, said the National Institute on Aging in Bethesda, Md., awarded the company an SBIR grant to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!